Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

XHEvsXPHETF Comparison

ETF 1
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
+0.43%
VS
ETF 2
XPH

State Street SPDR S&P Pharmaceuticals ETF

This fund is part of
US Health Care
+0.43%

State Street SPDR S&P Health Care Equipment ETF (XHE) and State Street SPDR S&P Pharmaceuticals ETF (XPH) belong to the same industry segment: US Health Care. XHE's top 3 sector exposures are Healthcare and Finance. In contrast, XPH's top sector exposures are Healthcare  Both XHE and XPH have the same Total Expense Ratio (TER) of 0.35%. XHE is down -0.75% year-to-date (YTD) with +$2M in YTD flows. XPH performs better with 22.32% YTD performance, and +$175M in YTD flows. Run a side-by-side ETF comparison of XHE and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs XPH performance and flow charts

Performance

-2.00.02.04.06.0%Jun 29Jul 7Jul 14Jul 21

Cumulative Flows

0 M10 M20 M30 M40 M50 M60 MJun 29Jul 7Jul 14Jul 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/27/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
XPH
+1.78%+3.23%
+5.94%+18.49%
-0.75%+22.32%
+10.33%+60.58%
-9.83%+68.59%
-30.38%+40.57%
Flows
XHE
XPH
+$2M+$61M
+$8M+$60M
+$2M+$175M
-$18M+$200M
-$382M+$128M
-$391M+$141M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
XPH
+26.58%+24.47%
+22.76%+22.24%
+22.23%+20.33%
+24.72%+20.88%
Max drawdown
XHE
XPH
-6.19%-8.13%
-18.20%-11.78%
-32.14%-23.45%
-49.90%-31.59%
Max drawdown duration
XHE
XPH
42d41d
200d50d
1093d322d
1789d1566d
Trading data

Create an account to view trading data

Join for free
XHE
XPH
Last sale
7/28/2026 at 1:30 PM
$89.59
$69.00
Previous close
07/27/2026
$87.54
$68.54
Consolidated volume
07/27/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
XPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
XHE
XPH
Last price
$89.59
$69.00
1D performance
+2.34%
+0.67%
AuM$155.25 M$479.27 M
E/R0.35%0.35%
Characteristics
XHE
XPH
Management strategyPassivePassive
ProviderState Street Investment ManagementState Street Investment Management
BenchmarkS&P Health Care Equipment Select Industry IndexS&P Pharmaceuticals Select Industry Index
N° of holdings6763
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011June 19, 2006
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
89.54%
Other
10.46%
XPH
USA
90.15%
Other
9.85%

Sectors

XHE
Healthcare
94.54%
Other
5.46%
XPH
Healthcare
94.73%
Other
5.27%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

26.73%
XPH

Total weight of top 15 holdings out of 15

29.74%

Top 15 holdings

Data as of June 30, 2026
XHE
Butterfly Network, Inc.
2.45%
QuidelOrtho Corp.
2.04%
Glaukos Corp.
1.79%
UFP Technologies, Inc.
1.79%
Axogen, Inc.
1.76%
Lantheus Holdings, Inc.
1.74%
Artivion, Inc.
1.73%
Envista Holdings Corp.
1.72%
Omnicell, Inc.
1.71%
Medline, Inc.
1.69%
Alphatec Holdings, Inc.
1.67%
Dentsply Sirona, Inc.
1.66%
Inspire Medical Systems, Inc.
1.66%
The Cooper Cos., Inc.
1.66%
Edwards Lifesciences Corp.
1.65%
XPH
MBX Biosciences, Inc.
2.72%
Alumis, Inc.
2.14%
Trevi Therapeutics, Inc.
2.12%
Enliven Therapeutics, Inc.
2.09%
Amylyx Pharmaceuticals, Inc.
2.04%
Veradermics, Inc.
2.02%
Ligand Pharmaceuticals, Inc.
1.94%
Nuvation Bio, Inc.
1.89%
Edgewise Therapeutics, Inc.
1.88%
Nektar Therapeutics
1.88%
Liquidia Corp.
1.86%
Maze Therapeutics, Inc.
1.85%
Harrow, Inc.
1.81%
EyePoint, Inc.
1.77%
Amneal Pharmaceuticals, Inc.
1.72%
Frequently asked questions about XHE and XPH

How have the XHE and XPH ETFs performed in 2026?

As of July 27, 2026, XHE is down -0.75% year-to-date (YTD), while XPH has returned 22.32%. That puts XPH better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or XPH?

Year-to-date, the XHE ETF saw +$2M in flows, compared to +$175M for XPH.

Which ETF is more volatile: XHE or XPH?

Over the past year, XHE had a volatility of 22.76%, while XPH experienced 22.24%.

Which ETF is bigger: XHE or XPH?

As of July 27, 2026, XHE holds $155.25 M in assets under management (AUM), while XPH manages $479.27 M.

What sectors do the XHE and XPH ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, XPH focuses on Healthcare.

What are the top holdings of the XHE ETF and XPH ETF?

XHE top holdings include Butterfly Network, Inc., QuidelOrtho Corp. and Glaukos Corp.. XPH holds in its top three: MBX Biosciences, Inc., Alumis, Inc. and Trevi Therapeutics, Inc..

Which ETF is more diversified: XHE or XPH?

XHE holds 67 securities with 26.73% of its assets in the top 15. XPH has 63 securities and a top 15 weight of 29.74%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder